Rapid healing of femoral defects in rats with low dose sustained BMP2 expression from PEGDA hydrogel microspheres

Journal of Orthopaedic Research

Volumn 31, Issue 10, 2013, Pages 1597-1604

  Sonnet, Corinne ^a   Simpson, C Lashan ^b   Olabisi, Ronke M ^b   Sullivan, Kayleigh ^a   Lazard, Zawaunyka ^a   Gugala, Zbigniew ^c   Peroni, John F ^d   Weh, J Michael ^d   Davis, Alan R ^a,e   West, Jennifer L ^b   Olmsted Davis, Elizabeth A ^a,e  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b Rice University   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d UNIVERSITY OF GEORGIA   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

BMP2; bone healing; critical size defect; microencapsulation; PEGDA

Indexed keywords

MICROSPHERE; POLY(ETHYLENE GLYCOL)DIACRYLATE; POLYMER; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEFECT; BONE REGENERATION; CONTROLLED STUDY; FEMUR DEFECT; HISTOLOGY; INFLAMMATORY CELL; LOW DRUG DOSE; MECHANICAL TORSION; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETON;

BMP2; BONE HEALING; CRITICAL SIZE DEFECT; MICROENCAPSULATION; PEGDA;

ANIMALS; BIOMECHANICS; BONE MORPHOGENETIC PROTEIN 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMPOUNDING; FEMORAL FRACTURES; FEMUR; FIBROBLASTS; FRACTURE HEALING; HYDROGEL; MICROSPHERES; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; SKIN; STROMAL CELLS;

EID: 84882838027     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22407     Document Type: Article

References (36)

1. Summers BN, Eisenstein SM., 1989. Donor site pain from the ilium. A complication of lumbar spine fusion. J Bone Joint Surg Br 71: 677-680.
2. Seiler JG III, Johnson J., 2000. Iliac crest autogenous bone grafting: donor site complications. J South Orthop Assoc 9: 91-97.
3. Govender S, Csimma C, Genant HK, et al. 2002. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A: 2123-2134.
4. Hwang CJ, Vaccaro AR, Lawrence JP, et al. 2009. Immunogenicity of bone morphogenetic proteins. J Neurosurg Spine 10: 443-451.
5. Winn SR, Hu Y, Sfeir C, et al. 2000. Gene therapy approaches for modulating bone regeneration. Adv Drug Deliv Rev 42: 121-138.
6. Jeon O, Song SJ, Kang SW, et al. 2007. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(l -lactic-co-glycolic acid) scaffold. Biomaterials 28: 2763-2771.
7. Carragee EJ, Hurwitz EL, Weiner BK., 2011. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J 11: 471-491.
8. Kang JD., 2011. Another complication associated with rhBMP-2 ? Spine J 11: 517-519.
9. Hutmacher DW, Woodruff MA, Shakesheff K, et al. 2012. Direct fabrication as a patient-targeted therapeutic in a clinical environment. Methods Mol Biol 868: 327-340.
10. Lutolf MP, Weber FE, Schmoekel HG, et al. 2003. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 21: 513-518.
11. Moutsatsos IK, Turgeman G, Zhou S, et al. 2001. Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 3: 449-461.
12. Chen Y, Luk KD, Cheung KM, et al. 2003. Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Gene Ther 10: 1345-1353.
13. Musgrave DS, Bosch P, Ghivizzani S, et al. 1999. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 24: 541-547.
14. Olmsted-Davis E, Gannon FH, Ozen M, et al. 2007. Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol 170: 620-632.
15. Dilling CF, Wada AM, Lazard ZW, et al. 2010. Vessel formation is induced prior to the appearance of cartilage in BMP-2-mediated heterotopic ossification. J Bone Miner Res 25: 1147-1156.
16. Olabisi RM, Lazard ZW, Franco CL, et al. 2010. Hydrogel microsphere encapsulation of a cell-based gene therapy system increases cell survival of injected cells, transgene expression, and bone volume in a model of heterotopic ossification. Tissue Eng A 16: 3727-3736.
17. Pathak CP, Sawhney AS, Hubbell JA., 1992. Rapid photopolymerization of immunoprotective gels in contact with cells and tissue. J Am Chem Soc 114: 8311-8312.
18. Cruise GM, Hegre OD, Lamberti FV, et al. 1999. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant 8: 293-306.
19. Ratner BD, Hoffman AS, Schoen FJ, et al. 2004. An introduction to materials in medicine. Biomater Sci Chapter II: 100-107.
20. Franco CL, Price J, West JL., 2011. Development and optimization of a dual-photoinitiator, emulsion-based technique for rapid generation of cell-laden hydrogel microspheres. Acta Biomater 7: 3267-3276.
21. Cruise GM, Scharp DS, Hubbell JA., 1998. Characterization of permeability and network structure of interfacially photopolymerized poly(ethylene glycol) diacrylate hydrogels. Biomaterials 19: 1287-1294.
22. Bikram M, Fouletier-Dilling C, Hipp JA, et al. 2007. Endochondral bone formation from hydrogel carriers loaded with BMP2-transduced cells. Ann Biomed Eng 35: 796-807.
23. Thies RS, Bauduy M, Ashton BA, et al. 1992. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 130: 1318-1324.
24. Olmsted EA, Blum JS, Rill D, et al. 2001. Adenovirus-mediated BMP2 expression in human bone marrow stromal cells. J Cell Biochem 82: 11-21.
25. Fouletier-Dilling CM, Bosch P, Davis AR, et al. 2005. Novel compound enables high-level adenovirus transduction in the absence of an adenovirus-specific receptor. Hum Gene Ther 16: 1287-1297.
26. Blum JS, Li RH, Mikos AG, et al. 2001. An optimized method for the chemiluminescent detection of alkaline phosphatase levels during osteodifferentiation by bone morphogenetic protein 2. J Cell Biochem 80: 532-537.
27. Rosset A, Spadola L, Ratib O, et al. 2004. An open-source software for navigating in multidimensional DICOM images. J Digit Imaging 17: 205-216.
28. Hoff BA, Kozloff KM, Boes JL, et al. 2012. Parametric response mapping of CT images provides early detection of local bone loss in a rat model of osteoporosis. Bone 51: 78-84.
29. Jaiswal N, Haynesworth SE, Caplan AI, et al. 1997. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64: 295-312.
30. Urist MR, Mikulski A, Lietze A., 1979. Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci USA 76: 1828-1832.
31. Mumaw J, Jordan ET, Sonnet C, et al. 2012. Rapid heterotrophic ossification with cryopreserved poly(ethylene glycol-) microencapsulated BMP2-expressing MSCs. Int J Biomater 2012: 861794.
32. Kolambkar YM, Dupont KM, Boerckel JD, et al. 2011. An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials 32: 65-74.
33. Salisbury E, Rodenberg E, Sonnet C, et al. 2011. Sensory nerve induced inflammation contributes to heterotopic ossification. J Cell Biochem 112: 2748-2758.
34. Salisbury E, Lazard Z, Ubogu EE, et al. 2012. Transient brown adipocyte-like cells derive from peripheral nerve progenitors in response to bone morphogenetic protein 2. Stem Cells Transl Med 12: 874-885.
35. Donegan DJ, Scolaro J, Matuszewski PE, et al. 2011. Staged bone grafting following placement of an antibiotic spacer block for the management of segmental long bone defects. Orthopedics 34: e730-e735.
36. Hsu CW, Olabisi RM, Olmsted-Davis EA, et al. 2011. Cathepsin K-sensitive poly(ethylene glycol) hydrogels for degradation in response to bone resorption. J Biomed Mater Res A 98: 53-62.